NDC Active Ingredient Goserelin Acetate

Active Ingredient Information

What is Goserelin Acetate?

A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.

What is the usage for Goserelin Acetate?

Goserelin is used in men to treat prostate cancer. It is used in women to treat certain breast cancers or a certain uterus disorder (endometriosis). It is also used in women to thin the lining of the uterus (endometrium) in preparation for a procedure to treat abnormal uterine bleeding. Talk to your doctor about the risks and benefits of treatment. Goserelin is similar to a natural hormone made by the body (luteinizing hormone releasing hormone-LHRH). It works by decreasing testosterone hormones in men and estrogen hormones in women. This effect helps to slow or stop the growth of certain cancer cells and uterine tissue that need these hormones to grow and spread.

How many products in the NDC database contain Goserelin Acetate?

The NDC database has 5 products with the active ingredient Goserelin Acetate. The following table lists all the products that have this active ingredient.

NDC Products with Goserelin Acetate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
55463-0005Proprietary Name: GoserelinPowderBachem AgACTIVE
60440-0960Proprietary Name: Goserelin AcetateImplantAstrazeneca Uk LimitedACTIVE
60440-0961Proprietary Name: Goserelin ImplantImplantAstrazeneca Uk LimitedACTIVE
70720-950Proprietary Name: Zoladex GoserelinImplantSubcutaneousTersera Therapeutics LlcACTIVE
70720-951Proprietary Name: Zoladex GoserelinImplantSubcutaneousTersera Therapeutics LlcACTIVE
<